Aleva, an EPFL spin-off, raises more than CHF10M of venture-capital.
© 2011 EPFL
A spin-off from Philippe Renaud's laboratory and backed with an Innogrant in 2008, Aleva Neurotherapeutics just closed its A round with CHF 10M. Co-founded by Andre Mercanzini,
Aleva is active in the field of neurostimulation et fighs the effectsof Parkinson's disease. More ...